Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Inventory Average (2023 - 2025)

Historic Inventory Average for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Q3 2025 value amounting to $20.5 million.

  • Rhythm Pharmaceuticals' Inventory Average rose 5828.73% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 5828.73%. This contributed to the annual value of $13.7 million for FY2024, which is 13711.12% up from last year.
  • According to the latest figures from Q3 2025, Rhythm Pharmaceuticals' Inventory Average is $20.5 million, which was up 5828.73% from $19.1 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Inventory Average high stood at $20.5 million for Q3 2025, and its period low was $4.2 million during Q1 2023.
  • Its 3-year average for Inventory Average is $12.0 million, with a median of $10.3 million in 2024.
  • Examining YoY changes over the last 5 years, Rhythm Pharmaceuticals' Inventory Average showed a top increase of 12215.28% in 2025 and a maximum decrease of 5828.73% in 2025.
  • Over the past 3 years, Rhythm Pharmaceuticals' Inventory Average (Quarter) stood at $8.2 million in 2023, then soared by 99.17% to $16.3 million in 2024, then increased by 25.56% to $20.5 million in 2025.
  • Its last three reported values are $20.5 million in Q3 2025, $19.1 million for Q2 2025, and $19.0 million during Q1 2025.